MCD Monthly Newsletter

Which MCD treatments help patients stay in remission longer?

If you're living with Minimal Change Disease, it's natural to wonder whether there are better treatment options, how likely another relapse is, and what new research could mean for your future.

MCD Monthly reviews the latest research on steroid alternatives, relapse prevention, and long-term outcomes, and explains what matters in plain English, so you can have more informed conversations with your nephrologist.

30 days free · Cancel anytime

Each issue highlights important findings, what they might mean for patients, and questions worth discussing with your care team.

A Look Inside MCD Monthly

Findings that could change the questions you ask about your MCD

These are the kinds of findings we highlight for subscribers. Each one gives you a clearer picture of your options and a more specific question to bring to your nephrologist.

August 2026 | Preventing relapses

90% vs. 66%: A big difference in staying relapse-free

In a study of adults with MCD or a closely related kidney condition, about 90% who received an additional rituximab dose remained relapse-free at two years, compared with 66% who did not. The timing of treatment may be as important to discuss as the treatment itself.

A question worth asking: If I have had more than one relapse, should we discuss scheduled rituximab doses rather than waiting until my MCD returns?
October 2026 | Getting off steroids

Could your immune cells help explain whether you can stop steroids?

Researchers found differences in immune-cell patterns between patients with steroid-dependent MCD who were able to stop steroids after rituximab and those who could not. This points to a more personalized way of understanding treatment response.

A question worth asking: What would tell us that I am ready to taper steroids, and how will we know early if that plan is not working?
August 2026 | Medicines and kidney health

An everyday pain reliever was linked to severe kidney injury and MCD

Doctors described a patient who developed MCD and sudden kidney failure after taking ibuprofen daily for two weeks. He temporarily required dialysis. It is a reminder that common over-the-counter medicines belong in your kidney-care conversations.

A question worth asking: Are the pain medicines I use safe with MCD, and which alternatives would you recommend for me?

MCD Monthly helps you understand published findings and prepare for informed conversations with your care team. Your nephrologist can help determine what applies to your situation.

Read Your First Issue Free
What You Get

Spend less time searching. Feel more informed about your MCD.

MCD treatment decisions aren't one-and-done. New evidence continues to emerge, and the questions that matter can change from diagnosis to remission to relapse.

  • Monthly MCD research updates covering treatments, relapse patterns, and emerging options.
  • Patient-friendly explanations of what each study found, and what it doesn't prove.
  • Questions for your next appointment to help you discuss relevant findings with your nephrologist.
  • Immediate access to recent issues, the report archive, and subscriber resources.
Included bonus: MCD Treatment Comparison Guide. A plain-English resource comparing commonly used treatments, including evidence on remission, relapse, and side effects. Also included: our other patient resources.
One Simple Subscription
$5/month

Your first 30 days are free. Explore a full issue and the included resources before deciding whether to continue.

Read Your First Issue Free
30 days free · Cancel anytime
Frequently Asked Questions

Questions about subscribing

Why subscribe when medical research is available online for free?⌄

Although some medical research is freely available, many journal articles are behind paywalls, and the studies that are accessible can be difficult to find and interpret. MCD Monthly does that work for you. We identify research relevant to patients with Minimal Change Disease, translate the key findings into plain English, and explain what they could mean for treatment options, relapse prevention, and conversations with your nephrologist. You get the useful insights without spending hours searching journals or paying to access individual articles.

Is there enough new Minimal Change Disease research to justify a monthly newsletter?⌄

More than 30 new articles and studies related to Minimal Change Disease are published in a typical month. The challenge is not a lack of information. It is knowing which findings matter to patients. We review the research and select the developments most relevant to treatment effectiveness, relapse prevention, side effects, and long-term outcomes. Each issue brings the findings together in one clear, manageable read, including questions you may want to raise with your nephrologist.

How is this different from advice from my nephrologist?⌄

Your nephrologist remains your primary source for medical advice and treatment decisions. MCD Monthly does not evaluate your individual situation or recommend changes to prescribed treatment. It is designed to help you understand published research and prepare more informed questions for your care team.

What is included in the free trial, and what will I pay afterward?⌄

Your first 30 days include full access to the latest monthly issue, previous reports, and subscriber resources, including the MCD Treatment Comparison Guide. The subscription costs $5 per month after the trial unless you cancel. You can review the material during your trial before deciding whether it is valuable to you.

Can I cancel if the newsletter is not useful for me?⌄

Yes. You may cancel during the 30-day free trial or at any time afterward. There is no long-term subscription commitment. If you cancel before your trial ends, you will not be charged for the following month.

You don't have to follow MCD research on your own.

Get clearer answers about treatment research, relapse risk, and what may be worth discussing with your doctor.

Read Your First Issue Free

30 days free · Cancel anytime · Then $5/month

MCD Monthly
30 days free · Cancel anytime
Read First Issue Free